Sivia Capital Partners’s AbbVie ABBV Stock Holding History

Sivia Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$423K	Hold	1,682	–	–	0.05%	390
2026 Q1	$366K	Sell	1,682 -3,367	-67%	-$747K	0.07%	320
2025 Q4	$1.15M	Buy	5,049 +44	+0.9%	+$10K	0.23%	89
2025 Q3	$1.16M	Buy	5,005 +434	+9%	+$88.4K	0.33%	48
2025 Q2	$848K	Buy	4,571 +51	+1%	+$9.48K	0.29%	54
2025 Q1	$947K	Buy	4,520 +248	+6%	+$48.2K	0.44%	30
2024 Q4	$759K	Sell	4,272 -221	-5%	-$40.6K	0.38%	35
2024 Q3	$887K	Buy	4,493 +98	+2%	+$18.3K	0.52%	32
2024 Q2	$754K	Buy	4,395 +177	+4%	+$29.3K	0.5%	31
2024 Q1	$768K	Buy	4,218 +529	+14%	+$91.2K	0.52%	28
2023 Q4	$572K	Buy	+3,689	New	+$538K	0.44%	37

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Sivia Capital Partners's ABBV Position: Q2 2026 in Review

Sivia Capital Partners held its AbbVie (ABBV) position steady in Q2 2026 at 1,682 shares worth $423K. The position accounts for 0.05% of the portfolio, ranked #390.

Sivia Capital Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.16M in Q3 2025. 1,417 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sivia Capital Partners held 1,682 shares of AbbVie worth $423K as of Q2 2026.
Sivia Capital Partners left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.05% of Sivia Capital Partners's portfolio in Q2 2026, its #390 holding.
Sivia Capital Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Sivia Capital Partners's AbbVie position peaked at $1.16M in Q3 2025.
1,417 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.